Onychomycosis Market Share is expected to increase at a dependable compound annual growth rate 6.29% CAGR By 2030


Onychomycosis Market Outlooks And Analysis by Type, Treatment Type, Distribution Channel and Region – Forecast till 2030. According to Market Research Future (MRFR)’s study, the global onychomycosis market is projected to strike a CAGR of 6.29% during the forecasted period 2022 to 2030. As onychomycosis majorly affects the elderly people, the growing geriatric population is one of the important drivers responsible for the expansion of the market.

The widespread incidence of diabetes is another factor that would favourably influence the expansion of the onychomycosis market in the next years. Changes in lifestyle and the growing burden of insufficient immunity are predicted to further accelerate market growth.

The growing public awareness of the disease has fueled the need for novel technology, cures, and pharmaceuticals. This was seen as a catalyst for the onychomycosis market to flourish throughout the ensuing years. On the other hand, during the course of the evaluation period, it is probable that factors including low healthcare spending and a lack of expertise in emerging nations will hamper the growth of the onychomycosis market.

Onychomycosis Market Leading Vendors includes

Abbott Laboratories Ltd. (US)

Pfizer Inc. (US)

Valeant Pharmaceuticals (Canada)

GlaxoSmithKline Plc. (UK)

Galderma (Switzerland)

Bristol Meyer Squibb company (US)

Cutera Inc. (US)

Janssen Biotech (US)

Sciton Inc (US)

Novartis AG (Switzerland)

Taro Pharmaceutical Industries Ltd. (US)

Seren Pharmaceuticals Pvt. Ltd (China)

Sanofi Ltd. (France)

Topica Pharmaceuticals Inc. (US)

Nuvo Research Inc. (Canada)

NanoBio Corporation (US)

NovaBiotics Ltd (UK)

Viamet Pharmaceuticals Inc. (US)

Merz Pharma gmbh & co. kgaa (Germany)

and Polichem SA (Switzerland)

Market Segmentation of onychomycosis market

By type, the global onychomycosis market share has been segmented into distal subungual onychomycosis, white superficial onychomycosis, proximal subungual onychomycosis, candida onychomycosis, and others.

By treatment, the onychomycosis market has been segmented into drug treatment, tropical therapy, debridement, and others.

By end-user, the global onychomycosis market has been segmented into hospital pharmacies, private pharmacies, and others.

Regional Analysis:

The global onychomycosis market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is likely to dominate the global market through the forecast period. It is projected to exhibit healthy growth over the next couple of years owing to the growing prevalence of onychomycosis in the region. Furthermore, the growing awareness about the diseases is also expected to have a favorable impact on the proliferation of the regional onychomycosis market in the forthcoming years.

Over the course of the evaluation period, Europe is expected to hold onto its previously assured second place. The region’s onychomycosis market is expected to grow as a result of the significant geriatric population there. Over the course of the research period, Asia Pacific is anticipated to see the fastest regional market growth. The rising elderly population and the rising diabetes load can be linked to the expansion of the regional onychomycosis market. The Middle East and Africa, on the other hand, are expected to experience modest growth over the next years. It is assumed that problems like weak socioeconomic conditions, restricted medical facility development, etc. will hinder the regional market’s growth.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com